Introduction
Diet certainly plays an important role in preventing cancer, but the mechanism is still not clear. Epidemiological evidence links consumption of fruits and/or vegetables with decreased risk of cancer (1) .
Reactive oxygen species produced in cells, largely as by-products of metabolic processes, constantly threaten the integrity and correct functioning of cellular DNA (2) . Several oxidant species have the capacity to produce promutagenic lesions in DNA (3) , which may play a significant role in the development of cancer. Fruits and vegetables contain relatively high amounts of components with inherent antioxidant properties, such as vitamin C, carotenoids and flavonoids, which has led to the suggestion that dietary antioxidants may augment cellular antioxidant defences and help protect cellular components from oxidative damage. Antioxidant activity is therefore considered to play an important role in the protective effects of fruits and vegetables against cancer (4, 5) .
b-Cryptoxanthin, one of the six major carotenoids routinely measured in human serum (b-carotene, lycopene, lutein, b-cryptoxanthin, zeaxanthin and a-carotene), is obtained primarily from citrus fruits (6) , but is also found in corn, peas and some yellow coloured animal products such as egg yolk and butter. Like other carotenoids, b-cryptoxanthin is an antioxidant and may help prevent free radical damage to biomolecules including lipids, proteins and nucleic acids. Retinoids, the cleavage products of carotenoids, as well as being antioxidants, have in some cases (including b-cryptoxanthin) vitamin A activity and may play an important role in the prevention and treatment of certain cancers (7, 8) .
There are several prospective studies investigating the possible effect of b-cryptoxanthin (and other carotenoids) on risk of various cancers. Toniolo et al. (9) found that levels of b-cryptoxanthin and lutein in serum were linked with reduced risk of breast cancer in a dosedependent fashion. A similar negative association of breast cancer risk with plasma carotenoid levels was reported by Tamimi et al. (10) . b-Carotene, lycopene, b-cryptoxanthin, zeaxanthin and lutein are reduced in colorectal adenomas, suggesting that mucosal carotenoids could serve as biomarkers for predisposition to colorectal cancer (11) . Women with high circulating concentrations of b-cryptoxanthin and tocopherol may be at a reduced risk of cervical atypical squamous cells of undetermined significance (12) . However, Dorgan et al. (13) found a positive association between several plasma carotenoids, including b-cryptoxanthin, and risk of squamous cell carcinoma in a 5 year follow-up trial of patients who had already had a non-melanoma skin cancer.
Supplementation trials with carotenoids, aimed at reducing risk of cancer, have had disappointing results. A recent meta-analysis (14) showed, if anything, an increase in cancer risk following supplementation with b-carotene, vitamin A and vitamin E, singly or in combination. Thus, carotenoids in general must be regarded with circumspection, and further investigations of their modes of action are warranted.
Here, we use the comet assay (alkaline single-cell gel electrophoresis) to investigate the ability of b-cryptoxanthin to protect against DNA oxidation damage in cultured Caco-2 and HeLa cells and also the possible enhancement of DNA repair (a second line of defence). The comet assay is a simple, fast and reliable method for measuring DNA strand breaks (SBs). A simple modification, incorporating digestion of DNA with lesion-specific enzymes, endonuclease III and formamidopyrimidine DNA glycosylase (FPG), allows measurement of oxidized pyrimidines and oxidized purines, respectively (15) . DNA repair can be studied with the comet assay in different ways. If cells are subjected to damage (strand breakage or base oxidation) and then incubated to allow them to repair, the lesions remaining can be measured at intervals. Alternatively, an in vitro approach can be used, in which a cell extract is incubated with lysed agarose-embedded substrate cells containing specific damage. The ability of the extract to introduce DNA breaks in the substrate cells reflects the activity of the enzymes responsible for the initial steps of repair, i.e. removing the lesion. The assay was tested on Ogg1 À and wild-type mouse fibroblast cell lines (16) : there was essentially no incision activity in the extract from the mutant cells, confirming that it measures principally 8-oxoguanine DNA glycosylase 1 (OGG1) enzyme activity.
Materials and methods

Cell culture
HeLa cells (derived from human cervical cancer) and Caco-2 cells (derived from human colon carcinoma) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics (100 U/ml penicillin and 100 lg/ml streptomycin). Cells were maintained as monolayer cultures at 37°C in a humidified atmosphere with 5% CO 2 and routinely passaged by trypsinization when nearly confluent.
Comet assay
Cells were trypsinized and resuspended in phosphate-buffered saline (PBS) at 10 6 cells/ml. Thirty microlitre of cell suspension was mixed with 140 ll of 1% low-melting point agarose, and two 70 ll aliquots were dropped onto a microscope slide precoated with 1% normal melting point agarose. Glass cover slips were placed on the drops of agarose, which were left to set at 4°C. The cover slips were removed and the agarose-embedded cells lysed for 1 h in 2.5 M NaCl, 0.1 M Na 2 EDTA, 0.1 M Tris and 1% Triton X-100, pH 10 at 4°C. This removes membranes and most cellular components, including histones, leaving the DNA attached to the nuclear matrix as a nucleoid. After lysis, slides for measurement of oxidized bases were washed three times in enzyme buffer [0.1 M KCl, 0.5 mM Na 2 EDTA, 40 mM N-2-hydroxyethylpiperazine-N#-2-ethanesulphonic acid (HEPES) and 0.2 mg/ml bovine serum albumin, pH 8.0] and then incubated for 30 min at 37°C with 45 ll of FPG or 45 ll of enzyme buffer [FPG was prepared as a crude extract from Escherichia coli containing an overproducing plasmid, obtained from Serge Boiteux (CEA, Fontenay aux Roses, France). It was not purified, as this would reduce its stability. Optimum incubation conditions were established using nucleoids with an excess of 8-oxo-7,8-dihydroguanine (8-oxoGua), prepared as described below for the in vitro repair assay.] In the in vitro assay for DNA repair, a similar (but shorter) incubation was carried out with cell extract (see below). For measurement of SBs, agarose-embedded cells were simply lysed. All slides were then placed in a horizontal electrophoresis tank and the DNA was allowed to unwind for 40 min in cold alkaline electrophoresis solution (0.3 M NaOH and 1 mM Na 2 EDTA, pH .13). Electrophoresis was carried out in this solution for 30 min at 25 V and $300 mA, in a cold room. The slides were washed in cold 0.4 M Tris buffer (pH 7.5) for 10 min to neutralize excess alkali and for 10 min in water and left to dry overnight.
Gels were stained with 25 ll of 4#,6-diamidino-2-phenylindole (1 lg/ml), covered with a cover slip and coded. Using a fluorescence microscope, 100 comets (50 on each gel) were visually classified into five categories, 0-4, representing increasing relative tail intensities. Summing the scores (0-4) of 100 comets therefore gives an overall score of between 0 and 400 arbitrary units (15) . 
Measuring in vitro repair
This in vitro assay (16) provides a measure of the incision activity of a cell extract provided with a DNA substrate from cells containing specific damagein this case, 8-oxoGua. These cells are embedded in agarose, lysed and incubated with the extract. Incision at damage sites is detected as SBs using the comet assay.
Preparation of substrate cells. Near-confluent HeLa cells were treated with 1 lM Ro and irradiated on ice with visible light (4 min at 33 cm) to induce 8-oxoGua, as the substrate for base excision repair (BER). Cells were then suspended in freezing medium (Dulbecco's modified Eagle's medium with 20% serum and 10% DMSO) at 10 6 cells/ml, frozen slowly to À80°C in 0.7 ml aliquots and kept at this temperature until needed. Near-confluent HeLa cells without treatment were also frozen in the same way.
Preparation of cell pellets and extracts. HeLa and Caco-2 cells were incubated with 0, 1 or 4 lM b-cryptoxanthin for 2 h at 37°C in the dark. They were washed with PBS, trypsinized and resuspended in cold PBS at 10 6 /ml. Cells were dispensed in equal aliquots of 1 ml, centrifuged at 14 000g, 4°C for 5 min, and the supernatant was completely removed leaving an almost dry pellet. Pellets were frozen by dropping into liquid nitrogen and stored at À80°C. On the day of the experiment, a pellet was thawed and resuspended in 33 ll of extraction buffer (45 mM HEPES, 0.4 M KCl, 1 mM ethylenediaminetetraacetic acid, 0.1 mM dithiothreitol and 10% glycerol, pH 7.8) to which Triton X-100 was added to 0.25% just before use. Vortex mixing for 5 s at top speed was followed by incubation for 5 min on ice and centrifugation at 14 000g, 4°C for 5 min. Twenty-eight microlitre of supernatant was removed and combined with 110 ll of cold reaction buffer (40 mM HEPES, 0.1 M KCl, 0.5 mM ethylenediaminetetraacetic acid and 0.2 mg/ml bovine serum albumin, pH 8).
The reaction. Pairs of gels containing $2 Â 10 4 substrate HeLa cells, with or without treatment with Ro plus light, in 70 ll of 1% low-melting point agarose in PBS were set on agarose-precoated glass slides, and cells were lysed for 1 h as in the standard comet assay (see above). Slides were washed for 3Â 5 min with reaction buffer. Thirty microlitre of extract was placed on each gel, covered with a cover slip and incubated for 10 min in a humid chamber at 37°C. To check whether b-cryptoxanthin present in the extract directly induces DNA breaks, substrate nucleoids from damaged or undamaged HeLa cells were treated with b-cryptoxanthin. In this case, b-cryptoxanthin in 10 ll DMSO at concentrations of 0.1, 0.4, 1 and 4 lM was mixed with extraction buffer plus 0.25% Triton X-100 and then diluted with reaction buffer following the same procedure as the one used to make extracts from cell pellets. The incubation was performed exactly as with the extracts.
As a negative control, 30 ll of a mixture (1:4) of extraction buffer plus 0.25% Triton X-100 and reaction buffer was used, and as a positive control FPG. After incubation, alkaline unwinding and electrophoresis proceeded as in the standard comet assay. Three independent experiments were performed using extracts from different cell cultures.
Western blotting Whole-cell extract. Aliquots of 10 7 HeLa and Caco-2 cells, untreated or after incubation for 2 h with 4 lM b-cryptoxanthin, were centrifuged and snap frozen as described above. Pellets were resuspended in 1 ml of cold radioimmunoprecipitation assay buffer [0.15 M NaCl, 25 mM Tris, 1% NP40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 2 mM dithiothreitol, 1Â proteinase inhibitor cocktail (Sigma-Aldrich, St Louis, MO), pH 7.5] and left on ice for 10 min. The suspension was sonicated and centrifuged at 16 000g for 20 min at 4°C to remove cell debris.
Nuclear extract. Frozen pellets were resuspended in an equal volume of cold nuclear extraction buffer 1 (10 mM KCl, 10 mM HEPES, 1.5 mM MgCl 2 , 1 mM dithiothreitol and 1Â proteinase inhibitor cocktail, pH 8.0) and left on ice for 15 min. The suspension was then forced four times through a 23-gauge needle, centrifuged at 16 000g for 20 s and the pellet resuspended in two-third of the original cell pellet volume of nuclear extraction buffer 2 (0.42 M NaCl, 20 mM HEPES, 1.5 mM MgCl 2 , 0.2 mM ethylenediaminetetraacetic acid, 1 mM dithiothreitol, 25% glycerol and 1Â proteinase inhibitor cocktail, pH 8.0). The suspension was stirred at 4°C for 30 min and centrifuged at 16 000g for 20 min at 4°C.
Western blots. Protein content in the supernatants was measured with the BioRad Protein Microassay. Aliquots of 60 lg were taken for hOGG1 detection, and aliquots of 10 lg for apurinic endonuclease 1 (APE1) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). They were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane using an XCell II blot module (Invitrogen, Carlsbad, CA). Primary antibodies used were polyclonal anti-hOGG1 (Santa Cruz Biotechnology, Santa Cruz, CA), monoclonal anti-APE1 (Abcam, Cambridge, UK) and monoclonal anti-GAPDH (Ambion, Applied Biosystems, Foster City, CA). The secondary apurinic-conjugated antibodies were goat anti-mouse (Santa Cruz Biotechnology) and goat anti-rabbbit (Sigma-Aldrich). Immunoblots were detected by enhanced chemifluorescence (GE Healthcare, Piscataway, NJ) and phosphorimaging (Typhoon 9410 variable mood imager system, GE Healthcare). Typhoon scans and images were processed and quantified with ImageQuant TL.
Statistical analysis
Statistical analysis was performed using the software SPSS 11.0. Data are presented as means ± SDs from three independent experiments. Total comet Stimulation of DNA repair by b-cryptoxanthin scores of the different groups were compared using the non-parametric MannWhitney U-test. P 0.05 was set as the level of significance. Protection against DNA damage We tested HeLa and Caco-2 cells for their resistance to DNA oxidation by treating them for 5 min with H 2 O 2 on ice to induce DNA SBs. There were significantly lower levels of DNA breaks in cells preincubated with b-cryptoxanthin compared with control cells (Figure 2A) , indicating an enhanced antioxidant defence.
Results
DNA damage
Ro plus light induces 8-oxoGua and gives a high level of SBs with FPG. When b-cryptoxanthin-pretreated cells were treated with Ro plus light and directly analyzed in the comet assay, a clear effect on DNA migration was seen; b-cryptoxanthin caused a concentrationrelated decrease in Ro-induced DNA damage ( Figure 2B ).
Cellular repair
The ability of HeLa and Caco-2 cells to rejoin SBs induced by H 2 O 2 in the absence and presence of b-cryptoxanthin was followed by measuring the residual damage after different times of incubation ( Figure 3) . In cells without b-cryptoxanthin, the t 1/2 for rejoining of breaks was $10 min for HeLa and 18 min for Caco-2; in b-cryptoxanthin-treated cells, t 1/2 decreased to 4 min for HeLa (both 1 and 4 lM) and to 10 and 4 min for Caco-2 (1 and 4 lM, respectively). In control cells, the level of SBs was constant during the entire repair incubation time, indicating that preparation and subsequent processing of the cells did not cause significant DNA damage.
We treated cells with Ro plus light to induce 8-oxoGua, and followed BER by measuring residual FPG-sensitive sites over a period of incubation with and without b-cryptoxanthin (Figure 4 ). Cells treated with b-cryptoxanthin repaired the damage more quickly than untreated cells; in HeLa cells, the t 1/2 of $135 min without b-cryptoxanthin decreased to 80 and 65 min with 1 and 4 lM b-cryptoxanthin, respectively. In Caco-2 cells, the t 1/2 decreased from $260 to 155 and 125 min with 1 and 4 lM b-cryptoxanthin, respectively.
In vitro repair
The capacity of HeLa and Caco-2 cell extracts for BER of oxidized bases was assessed with and without b-cryptoxanthin pretreatment using an in vitro assay. HeLa and Caco-2 cells were incubated for 2 h with 0, 1 or 4 lM b-cryptoxanthin before preparation of a whole-cell extract. Extracts were then incubated with substrate nucleoids containing 8-oxoGua or without lesions, and incision was detected using the comet assay. Mixed extraction plus reaction buffer and FPG were used as negative and positive controls. Figure 5 shows a significant increase in incision by the extracts of cells treated with b-cryptoxanthin in nucleoids containing 8-oxoGua ( Figure 5A ), even after the low concentration of 1 lM, but no increase in breaks in nucleoids without lesions ( Figure 5B) .
b-Cryptoxanthin per se did not induce any breaks in nucleoids containing 8-oxoGua or nucleoids without lesions (data not shown).
Western blots
The glycosylase primarily associated with repair of oxidized purines in eukaryotes is OGG1. Removal of the base is followed by cutting at the apurinic site by APE1 (17) . The increased BER of 8-oxoGua might be due to an increase in cellular concentration of these proteins. We therefore carried out western blots on whole-cell extract and nuclear extract from HeLa and Caco-2 cells with and without pretreatment with b-cryptoxanthin. Results are shown in Figure 6 . APE1 was readily detected in both whole-cell and nuclear extracts. hOGG1 was much less intense and was especially difficult to detect in wholecell extract (therefore only results with nuclear extract are shown). After normalizing band intensities against the reference anti-GAPDH, only minor differences were seen (the most pronounced being an $50% decrease in anti-APE1 intensity in whole-cell extract from Caco-2 cells with b-cryptoxanthin). We conclude that the increase in OGG activity of the cell extract is not related to a detectable increase in enzyme concentration. 
Discussion
In addition to clinical studies, where carotenoids have been investigated in terms of cancer risk, numerous investigations have focused on DNA damage as an end point, rather than disease incidence. Both observational studies and intervention trials have been carried out. Plasma carotenoid concentrations were measured in a group of 40 healthy Spanish subjects (18) . Total carotenoids, lutein and b-carotene (though not b-cryptoxanthin) showed significant negative correlations with endonuclease III-sensitive sites (oxidized pyrimidines) in lymphocyte DNA. Similarly, Haegele et al. (19) reported inverse associations of lutein and b-cryptoxanthin with 8-oxodGuo in DNA measured by high-performance liquid chromatography. Also using high-performance liquid chromatography, Mecocci et al. (20) found that 8-oxodGuo in lymphocyte DNA was high and most plasma carotenoids were low in patients with Alzheimer disease compared with matched healthy controls-and that among the patients there was an inverse correlation between 8-oxodGuo and plasma concentrations of several carotenoids. Urinary 8-oxodGuo-a biomarker for oxidative stress (though the origin of the 8-oxodGuo has not been proven)-was measured by Thomson et al. (21) in a group of breast cancer survivors; there were negative correlations with several plasma carotenoids, including b-cryptoxanthin. It should be remembered that, in association studies of this sort, plasma carotenoids may simply be a marker of consumption of fruits and vegetables, and some other unidentified components may be responsible for the effect on DNA damage.
In an interesting contradictory study, Bianchini et al. In our experiments applying b-cryptoxanthin to cells in culture, there was a clear, dose-dependent antioxidant-protective effect, decreasing the breaks induced by H 2 O 2 even at a concentration as low as 1 lM (in the case of Caco-2 cells). Perhaps more impressively, Roinduced base oxidation was also markedly decreased, in both cell types at 1 lM. The mean plasma concentrations of b-cryptoxanthin vary from country to country and between men and women (27) , the highest levels in that study being found in women in Spain (0.42 lM). Thus, our effective concentration is close to the physiological range. Bearing in mind that b-cryptoxanthin is one of several carotenoids that probably act as antioxidants in concert, our results are likely to have biological relevance.
Effects of carotenoids on DNA repair have received less attention than antioxidant actions. We reported an apparent enhancement of SB rejoining in lymphocytes isolated from some but not all subjects 24 h after a single large dose of b-carotene, lutein or lycopene (28, 29) ; but we concluded that this effect might simply be an antioxidantprotective effect against additional damage induced by atmospheric oxygen since the freshly isolated lymphocytes were subject to a sudden increase in ambient oxygen concentration.
This consideration does not apply to the cultured cells used in the current investigation. b-Cryptoxanthin at 1 lM approximately doubled the rate at which HeLa and Caco-2 cells rejoin H 2 O 2 -induced SBs and had a proportionately similar effect on the intrinsically much slower repair of oxidized bases. That this truly reflects an increase in repair activity is confirmed by the experiments in which cell extracts were incubated in vitro with substrate DNA containing 8-oxoGua; b-cryptoxanthin preincubation of the cells significantly stimulated incision activity. Control experiments exclude the possibility that b-cryptoxanthin itself causes breaks or that it induces non-specific nuclease activity in the extracts. The increase in activity was not explained by any detectable increase in concentration of hOGG1 or of APE1, the two enzymes involved in removing 8-oxoGua and incising the DNA. This agrees with our previous finding that an increase in OGG activity resulting from kiwifruit consumption was not accompanied by any change in expression of hOGG1 or APE1 (30) and with the report of Paz-Elizur et al. (31) that there is a poor correlation between OGG1 activity and hOGG1 messenger RNA levels. It is possible that b-cryptoxanthin is involved in the post-translational regulation of OGG1 or APE1. OGG1 is regulated by phosphorylation (32) and also by acetylation (33) , and APE1, as well as being inactivated by phosphorylation (34) , is subject to redox regulation by reduction/oxidation at a cysteine adjacent to the active site (35). Astley et al. (36) treated Molt-17 human lymphocytes (a permanent line) with b-carotene, b-cryptoxanthin or lutein and found no evidence of antioxidant protection against DNA damage, although apparently carotenoids were required for any SB rejoining to occur over a 2 h incubation after H 2 O 2 treatment. There was no sign of an increase in repair activity in an in vitro assay (with oxidation damage in the substrate). Subsequently, lymphocytes from volunteers following various dietary regimes were tested; after a 3 week intervention with cooked carrots (200 g daily), in vitro repair was enhanced, and after mixed carotene capsules, SB rejoining was more rapid (37) . In summary, in our cell culture model system, we report effects of b-cryptoxanthin on levels of DNA oxidation that are consistent with a significant role as an antioxidant in vivo. In addition, b-cryptoxanthin has a striking stimulatory effect on two kinds of DNA repair-SB rejoining and excision repair of oxidized bases. The repair incision activity of a whole-cell extract is also stimulated by this phytochemical. Thus, the cancer-protective role of carotenoids, as seen in observational epidemiological studies, is probably in part at least the result of a stimulation of DNA repair. 
